New Therapeutic Agent Eluxadoline Can Offer Relief to Men and Women Suffering from IBS with Diarrhea
Eluxadoline (Viberzi, Allergan), a new oral agent with mixed opioid effects, has met fairly stringent criteria for treatment response in men and women with irritable bowel syndrome (IBS) with predominant diarrhea, according to two phase 3 clinical trials published in the January 21 issue of the New England Journal of Medicine (read it here). “Our [...]